Theriva Biologics, Inc. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share
Theriva Biologics, Inc. (TOVX) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share of $0.00 per share for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare · last filed 2015-03-16
- Theriva Biologics, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2013-09-30 was $0.00.
- Theriva Biologics, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2013-06-30 was $0.00.
- Theriva Biologics, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- Theriva Biologics, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2012-09-30 was $0.00.
- Theriva Biologics, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2014 was $0.00.
- Theriva Biologics, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Theriva Biologics, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2012 was $0.01.
- Theriva Biologics, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2011 was -$0.02.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-16 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 | |||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | ||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-15 | |||
| 2012-12-31 | $0.01 10-K · filed 2015-03-16 | |||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-14 | $0.01 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-14 | $0.02 10-Q · filed 2013-08-14 | ||
| 2012-03-31 | $0.02 10-Q · filed 2013-05-15 | |||
| 2011-12-31 | -$0.02 10-K · filed 2013-04-16 | |||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-11 | $0.00 10-Q/A · filed 2012-09-11 | ||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | |||
| 2010-12-31 | -$0.02 10-K/A · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |